Puma Biotechnology (PBYI) Finished Goods (2020 - 2026)

Puma Biotechnology (PBYI) has 7 years of Finished Goods data on file, last reported at $767000.0 in Q1 2026.

• Quarterly Finished Goods rose 36.72% year-over-year to $767000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $767000.0 (up 36.72% YoY) and the FY2025 annual result came in at $960000.0, up 22.61% from the prior year.
• Finished Goods slipped to $767000.0 in Q1 2026, from $960000.0 in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $1.6 million in Q1 2022 to a low of $186000.0 in Q4 2022.
• A 5-year average of $696000.0 and a median of $642000.0 in 2022 frame the typical range for Finished Goods.
• Annual changes were most pronounced in 2022 — Finished Goods plunged 83.9% — and 2023, when it jumped 204.84%.
• Tracing PBYI's Finished Goods over 5 years: stood at $186000.0 in 2022, then jumped by 204.84% to $567000.0 in 2023, then soared by 38.1% to $783000.0 in 2024, then increased by 22.61% to $960000.0 in 2025, then decreased by 20.1% to $767000.0 in 2026.
• The last three Finished Goods figures came in at $767000.0 (Q1 2026), $960000.0 (Q4 2025), and $439000.0 (Q3 2025), per Business Quant data.